Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme.

J Infect Dis. 2005 Sep 15;192(6):958-66. Epub 2005 Aug 15. Erratum in: J Infect Dis. 2005 Oct 15;192(8):1501.

PMID:
16107947
2.

Transmission of HIV-1 drug resistance.

Tang JW, Pillay D.

J Clin Virol. 2004 May;30(1):1-10. Review.

PMID:
15072747
3.

Characterization and structural analysis of HIV-1 integrase conservation.

Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.

AIDS Rev. 2009 Jan-Mar;11(1):17-29. Review.

PMID:
19290031
4.

Diversity of thymidine analogue resistance genotypes among newly diagnosed HIV-1-infected persons.

García-Lerma JG.

J Antimicrob Chemother. 2005 Aug;56(2):265-9. Epub 2005 Jun 10. Review.

PMID:
15951354
5.

Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection.

Booth CL, Geretti AM.

J Antimicrob Chemother. 2007 Jun;59(6):1047-56. Epub 2007 Apr 19. Review.

PMID:
17449483
6.

Epidemiological aspects of transmitted HIV drug resistance.

Girardi E.

Scand J Infect Dis Suppl. 2003;106:17-20. Review.

PMID:
15000576
7.

Impact of HIV-1 pol diversity on drug resistance and its clinical implications.

Kantor R.

Curr Opin Infect Dis. 2006 Dec;19(6):594-606. Review.

PMID:
17075337
8.

Transmission and prevalence of HIV resistance among treatment-naive subjects.

Little SJ.

Antivir Ther. 2000 Mar;5(1):33-40. Review.

PMID:
10846591
9.

The impact of HIV-1 subtype on the clinical response on HAART.

Frater J.

J HIV Ther. 2002 Nov;7(4):92-6. Review.

PMID:
12733607
10.

Evolutionary pathways of transmitted drug-resistant HIV-1.

Pingen M, Nijhuis M, de Bruijn JA, Boucher CA, Wensing AM.

J Antimicrob Chemother. 2011 Jul;66(7):1467-80. doi: 10.1093/jac/dkr157. Epub 2011 Apr 18. Review.

PMID:
21502281
11.

Can modulation of viral fitness represent a target for anti-HIV-1 strategies?

Clementi M.

New Microbiol. 2004 Jul;27(3):207-14. Review.

PMID:
15460522
12.

Supplemental Content

Support Center